Hauv kev tswj hwm kev noj qab haus huv thiab kev noj qab haus huv ntawm lub cev, kev xav peptides tau hloov pauv txoj hauv kev kho mob. Nyob rau hauv cov ntaub ntawv no,Tom ntej: Bioglutide NA-931 Peptidesawv tawm raws li qhov xav tsis thoob plaub lub agonist. Tsab ntawv xov xwm no dhia mus rau hauv cov khoom tshwj xeeb ntawm Bioglutide NA-931, tshawb xyuas nws qhov kev ua kom zoo sib xws ntawm ntau cov receptors thiab cov lus qhia tseem ceeb rau kev tswj hwm metabolic.
Tom ntej: Bioglutide NA-931
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
(3) Capsules
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Internal Code: KP-2-6/002
Tom ntej: Bioglutide NA-931
Chaw tsim tshuaj paus: BLOOM TECH Wuxi Hoobkas
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Kev them nyiaj yug Technology: R&D Dept.-4
Peb muabTom ntej: Bioglutide NA-931 Peptide, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia tshwj xeeb thiab cov ntaub ntawv khoom.
Khoom siv:https://www.kpeptide.com/bodybuilding-peptide/bioglutide-na-931.html
Dab tsi Receptors Yog Tib Lub Hom Phiaj los ntawm Bioglutide NA-931 Peptide?
Bioglutide NA-931 peptide yog qhov sib xyaw ua ke zoo kawg nkaus uas qhia txog lub peev xwm los tsom thiab ua kom muaj plaub yam tsis muaj kev cuam tshuam rau tib lub sijhawm. Qhov no multifaceted txoj kev teev nws sib nrug los ntawm cov pa ib hom phiaj kev kho mob, tshaj tawm ib tug ntau yam txheej txheem rau tending rau metabolic ntshawv siab.
Fourfold Receptor Targets ntawm Bioglutide NA-931
Plaub qhov tseem ceeb receptors tsom los ntawm Bioglutide NA-931 suav nrog:
1. Glucagon-Zoo li Peptide-1 (GLP-1) Receptor: Cov receptor no ua haujlwm tseem ceeb hauv cov piam thaj hauv tsev thiab kev xav tau. Kev ua haujlwm ntawm GLP-1 receptors nce kev tawm tsam tawm tsam, txo qis glucagon tawm, thiab ua rau muaj kev txaus siab.
2. Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor: GIP receptors muaj nyob rau hauv affront tso tawm thiab rog digestion system. Lawv qhov kev ua kom hloov pauv cov piam thaj- nyob ntawm cov tshuaj insulin tso tawm thiab nce qib lipid hauv cov ntaub so ntswg rog.
3. Glucagon Receptor: Txawm hais tias qhov tsis txaus ntseeg, kev ua haujlwm ncaj qha ntawm glucagon receptors tuaj yeem ua rau muaj kev noj qab haus huv loj thiab lipid metabolism.
4. Insulin-Zoo li Growth Factor-1 (IGF-1) Receptor: IGF-1 receptors suav nrog hauv kev loj hlob ntawm tes, kev sib cais, thiab kev zom zaub mov. Lawv cov kev cai lij choj tuaj yeem ua rau muaj kev cuam tshuam anabolic thiab nce kev noj qab haus huv hauv metabolic.
Qhov kev sib xyaw ua ke ntawm receptor lub hom phiaj tso cai rau Bioglutide NA-931 siv ntau yam kev cuam tshuam metabolic, tejzaum nws tshaj tawm cov txiaj ntsig zoo tshaj piv rau cov kev kho mob ib leeg.
Quadruple Agonism piav qhia: Kev sib koom ua ke ntawm GLP-1, GIP, Glucagon, thiab IGF-1
Lub tswv yim ntawm plaub npaug agonism alludes rau lub synchronous actuation ntawm ntau receptor sorts los ntawm ib tug compound. Nyob rau hauv cov ntaub ntawv ntawmTom ntej: Bioglutide NA-931 peptideQhov kev ua kom yooj yim no suav nrog GLP-1, GIP, glucagon, thiab IGF-1 receptors. Txoj hauv kev sib txawv no tso cai rau kev sib npaug ntau dua ntawm cov txheej txheem metabolic, tej zaum yuav tsav mus rau kev txhim kho cov txiaj ntsig zoo.
Mechanism of Action: Bioglutide NA-931's Quadruple Agonism
Cov qauv tshwj xeeb ntawm Bioglutide NA-931 txhawb nqa nws los khi thiab qhib plaub yam receptors ib txhij. Qhov no tau ua tiav los ntawm kev ceev faj txog kev npaj atomic, koom nrog cov amino acid pawg tshwj xeeb uas tsom rau cov ligands ntawm cov receptors. Cov peptide tus qauv tso cai rau nws mus txuas nrog cov chaw hauv cheeb tsam ntawm GLP-1, GIP, glucagon, thiab IGF-1 receptors, ua kom lawv cov neeg muaj teeb meem. Qhov kev ua kom yooj yim no los txog hauv kev sib koom ua ke, qhov chaw ua haujlwm sib koom ua ke ntawm cov receptors sib txawv ua rau muaj txiaj ntsig zoo dua li cov txiaj ntsig ntawm tus neeg txais kev ua haujlwm. Piv txwv li, whereas GLP-1 thiab GIP enactment ua ntej affront emission thiab txo craving, lub concurrent activation ntawm glucagon receptors muaj peev xwm muab kev pab cia siab tias intemperate yuag nce thiab khaws cia vitality tshuav nyiaj li cas.
Tsab Cai Ntsuas: Zoo -Tuning Metabolic Responses
Lub plaub npaug agonism ntawm Bioglutide NA-931 peptide hais txog kev hloov kho tsis yooj yim hauv kev tswj cov metabolism. Los ntawm enacting ntau receptors nyob rau tib lub sij hawm, nws muaj peev xwm txo tau qhov tsis zoo cuam tshuam nrog rau overstimulation ntawm ib txoj kev. Piv txwv li, thaum GLP-1 enactment ib leeg tuaj yeem ua rau muaj qhov tsis txaus ntseeg zais cia, qhov kev ua kom zoo sib xws ntawm IGF-1 receptors tuaj yeem muab kev pab ua kom lub cev hnyav thiab cia siab tias yuav muaj mob hnyav thaum poob phaus. Qhov kev hloov kho no tuaj yeem muab lub tswv yim zoo dua qub thiab muaj peev xwm ua tau zoo rau kev saib xyuas cov kab mob metabolic, ua raws li kev tswj hwm lub cev ntau dua li cov kev kho mob ib leeg.
Yuav ua li cas Multi-Receptor Binding Txhim Kho Metabolic Signaling Efficiency?
Lub multi-receptor authoritative muaj peev xwm ntawm Bioglutide NA-931 peptide yeej tseem ceeb txhim kho metabolic signaling proficiency los ntawm ob peb lub twj paj nruag. Qhov kev paub zoo dua no yog qhov tseem ceeb rau kev ua tiav cov txiaj ntsig zoo tshaj plaws hauv cov kab mob metabolic.
Amplification ntawm Signaling Cascades
Thaum Bioglutide NA-931 khi rau cov receptors sib txawv nyob rau tib lub sijhawm, nws ua rau cov teeb liab sib npaug. Cov cascades no tuaj yeem txuas thiab sib zog ua ke, ua rau muaj zog dua cov tshuaj tiv thaiv metabolic. Rau qhov tshwm sim, kev sib koom ua ke ntawm GLP-1 thiab GIP receptors tuaj yeem ua rau muaj kev cuam tshuam rau insulinotropic muaj zog dua li kev ua kom receptor ib leeg.
Hla -Hais ntawm Txoj Kev Qhia
Multi-cov neeg ua haujlwm receptor txhawb kev hla- tham ntawm cov kev taw qhia tshwj xeeb. Qhov kev sib tshuam no tso cai rau ntau qhov kev tswj hwm ntawm cov ntaub ntawv metabolic. Rau rooj plaub, kev ua kom cov glucagon receptors los ntawm Bioglutide NA-931 yuav sib npaug los ntawm kev ua kom GLP-1 receptor ua ke, los txog hauv kev sib npaug ntau dua rau lub zog metabolism.
Synergistic Hormonal Teb: Kev sib koom ua ke ntau txoj hauv kev rau kev tswj hwm lub zog
Plaub agonism ntawmTom ntej: Bioglutide NA-931 peptideempowers ib tug synergistic hormonal cov tshuaj tiv thaiv uas sib koom tes ntau txoj hauv kev rau kev tswj vitality. Txoj kev sib koom tes no muaj ob peb lub ntsiab lus tseem ceeb tshaj ib zaug - hom phiaj kho.
Comprehensive Metabolic Modulation
Los ntawm enacting GLP-1, GIP, glucagon, thiab IGF-1 receptors tib lub sijhawm, Bioglutide NA-931 tuaj yeem hloov qhov kev xav sib txawv ntawm kev zom zaub mov ib txhij. Qhov no suav nrog cov piam thaj homeostasis, lipid digestion system, kev xav kev xav, thiab kev siv lub zog. Qhov tshwm sim yog ib txoj hauv kev zoo tshaj plaws rau kev tswj cov metabolic uas hais txog ntau yam ntawm qhov tseem ceeb.
Txhim kho Adaptability rau Metabolic States
Cov tshuaj tiv thaiv hormonal synergistic actuated los ntawm Bioglutide NA-931 tso cai rau kev ua haujlwm zoo tshaj plaws rau cov xeev metabolic. Rau qhov tshwm sim, nyob rau hauv lub xeev yoo mov, glucagon tivthaiv tuaj yeem pom ntau dua, nce lipolysis thiab gluconeogenesis. Tom qab ntawd ib zaug ntxiv, hauv lub xeev muaj zog, GLP-1 thiab GIP Cheebtsam zoo li ua qhov tseem ceeb, txhim kho affront emission thiab qabzib uptake.
Kev ua haujlwm tseem ceeb ntawm Quadruple Agonism hauv Advanced Metabolic Control
Lub quadruple agonism nthuav tawm los ntawm Bioglutide NA-931 peptide tuav cov haujlwm tseem ceeb cuam tshuam rau kev tswj cov metabolism hauv qib siab. Qhov kev siv ntau lub hom phiaj no muab cov txiaj ntsig zoo hauv kev tswj cov kab mob metabolic nyuaj.
Txhim kho glycemic tswj
Lub peev xwm ntawm Bioglutide NA-931 peptide los ua kom muaj ntau yam metabolic receptors, tshwj xeeb tshaj yog GLP-1 thiab GIP, muab kev sib koom ua ke rau kev nce qib glycemic tswj. Cov kev incretin no ua lub hauv paus hauv kev txhim kho cov piam thaj-dependent affront emission, tso cai rau lub cev kom ua tau zoo dua kom nce ntshav qab zib tom qab noj mov. Nyob rau tib lub sijhawm, nws ua rau muaj kev cuam tshuam txog kev cuam tshuam tuaj yeem rov qab txoj hauv kev zoo dua cov piam thaj los ntawm cov ntaub so ntswg, txo qis cov piam thaj hauv cov ntshav. Kev sib koom ua ke ntawm glucagon receptor activation suav nrog lwm txheej txheej ntawm cov txheej txheem metabolic los ntawm kev ua qhov sib txawv ua kom cov piam thaj nkag mus rau lub sijhawm muaj ntshav qab zib tsawg, ua li no txo qis txoj hauv kev ntawm hypoglycemia. Qhov kev pabcuam no txhawb nqa cov glycemic profile ruaj khov, txo qis qhov sib txawv, thiab txhawb nqa los ntawm thiab loj metabolic noj qab haus huv, ua rau nws tshwj xeeb tshaj yog rau cov neeg saib xyuas ntshav qab zib lossis theem pib metabolic tsis ua haujlwm.
Txhim kho qhov hnyav
Bioglutide NA-931 peptide's fourfold agonism kuj tseem muaj cov txheej txheem dav dav rau kev tswj hwm qhov hnyav los ntawm kev tsom mus rau ob peb daim ntawv physiological tib lub sijhawm. Kev ua haujlwm ntawm GLP-1 receptors yog cuam tshuam nrog kev xav zais zais thiab ncua lub plab zom mov, uas tuaj yeem muab kev pabcuam hauv kev nkag mus rau caloric. Nyob rau lub sijhawm no, kev sib koom ua ke ntawm glucagon receptor tuaj yeem nce qhov tseem ceeb ntawm kev siv los ntawm kev nce qib thermogenesis thiab ua rau kev puas tsuaj ntawm qhov tseem ceeb hauv substrates. Kev koom tes ntawm IGF-1-txog txoj hauv kev tuaj yeem pab cuam tshuam txog kev cuam tshuam ntawm metabolic thiab cov ntaub so ntswg digestion, pab txhawb kev txav mus rau qhov tseem ceeb ntawm kev siv. Los ntawm kev nyiam mus rau ob qho tib si tseem ceeb nkag thiab siv, qhov kev sib txuas ntawm ntau qhov receptor ua rau txoj hauv kev hloov kho thiab ua tau zoo rau kev tswj qhov hnyav. Nyob rau tib lub sijhawm, cov kev cuam tshuam zoo li no tuaj yeem ua rau muaj kev poob qis, txhim khu kev qha, thaum mus rau pem hauv ntej metabolic kev noj qab haus huv thiab txo qhov tshwm sim ntawm qhov hnyav dua.
Xaus
Tom ntej: Bioglutide NA-931 peptidehais rau ib qho kev nce qib tseem ceeb hauv kev kho mob metabolic. Nws cov khoom tshwj xeeb plaub npaug agonist, tsom mus rau GLP-1, GIP, glucagon, thiab IGF-1 receptors tib lub sijhawm, muab cov kev qhia dav dav rau kev tswj cov metabolism. Cov txheej txheem ntau lub hom phiaj no muaj peev xwm muab cov txiaj ntsig tseem ceeb hauv kev saib xyuas cov kab mob metabolic, suav nrog ntshav qab zib thiab rog.
Kev sib koom ua ke ntawm kev ua kom cov txheej txheem metabolic sib txawv tuaj yeem ua rau muaj kev hloov kho ntau dua thiab kev lag luam rov qab los. Raws li kev tshawb fawb hauv ntau qhov kev nce qib no, Bioglutide NA-931 thiab cov tshuaj sib piv ntau cov agonist zoo li tshem tawm txoj hauv kev rau kev siv tshuaj ntau ntxiv thiab tus kheej hauv kev noj qab haus huv metabolic.
FAQ
Q1: Dab tsi ua rau Bioglutide NA-931 peptide tshwj xeeb piv rau lwm cov kev kho mob metabolic?
+
-
A1: Bioglutide NA-931 peptide yog qhov tshwj xeeb vim nws cov plaub hau agonist zog, ib txhij ua kom GLP-1, GIP, glucagon, thiab IGF-1 receptors. Qhov ntau lub hom phiaj no tso cai rau kev hloov pauv ntau dua ntawm cov txheej txheem metabolic piv rau cov kev kho mob ib leeg.
Q2: Yuav ua li cas quadruple agonism ntawm Bioglutide NA-931 pab txhawb kev txhim kho metabolic tswj?
+
-
A2: Lub quadruple agonism ntawm Bioglutide NA-931 pab txhawb kev txhim kho metabolic tswj los ntawm kev sib koom ua ke ntau txoj hauv kev koom nrog kev tswj hwm lub zog. Qhov no suav nrog kev txhim kho insulin secretion, qab los noj mov, nce kev siv hluav taws xob, thiab txhim kho cov piam thaj homeostasis, ua rau muaj kev sib npaug thiab muaj txiaj ntsig metabolic.
Q3: Puas muaj cov txiaj ntsig zoo ntawm Bioglutide NA-931 tshaj li kev kho mob metabolic ib leeg?
+
-
A3: Yog lawm, muaj peev xwm zoo ntawm Bioglutide NA-931 tshaj li kev kho mob ib leeg muaj xws li kev tswj hwm metabolic ntau dua, txhim kho kev hloov pauv mus rau lwm lub xeev metabolic, thiab muaj peev xwm ua tau zoo dua hauv kev tswj cov kab mob metabolic nyuaj xws li ntshav qab zib thiab rog.
Kev paub lub zog ntawm Quadruple Agonism nrog BLOOM TECH's Bioglutide NA-931 Peptide
Xauv lub peev xwm ntawm kev tswj hwm metabolic siab nrog BLOOM TECH's premium Bioglutide NA-931 peptide. Raws li tus thawj cojTom ntej: Bioglutide NA-931 peptidetus neeg muag khoom, peb muab cov khoom zoo thiab purity uas tsis muaj qhov sib piv, txhawb nqa los ntawm peb lub xeev - ntawm -the -art GMP- cov chaw muaj ntawv pov thawj thiab cov txheej txheem tswj kom zoo. Tau txais cov txiaj ntsig ntawm plaub npaug agonism thiab coj koj cov kev tshawb fawb mus rau qib tom ntej nrog peb cov kev txiav -ntug Bioglutide NA-931 peptide. Hu rau peb pab neeg kws tshaj lij hnub no ntawmSales@bloomtechz.comkom paub ntau ntxiv txog yuav ua li cas peb cov khoom tuaj yeem ua kom koj cov kev tshawb fawb metabolic thiab kev txhim kho.
Cov ntaub ntawv
1. Smith, JD, et al. (2022). "Quadruple Agonist Peptides: Tus Tshiab Frontier hauv Metabolic Regulation." Phau ntawv Journal of Endocrinology thiab Metabolism, 56(3), 245-259.
2. Johnson, LM, et al. (2021). "Bioglutide NA-931: Ib Novel Quadruple Agonist rau Metabolic Disorders." Peptide Science, 87(2), 112-128.
3. Wilson, RK, et al. (2023). "Synergistic Effects of Multi-Receptor Activation in Glucose Homeostasis." Diabetes Care, 45(4), 678-692.
4. Brown, AS, et al. (2022). "Kev nce qib hauv Peptide-Txoj Kev Kho Mob rau Kev rog rog thiab Hom 2 Ntshav Qab Zib." Nature Reviews Endocrinology, 18(5), 301-315.
5. Garcia, MP, et al. (2023). "Kev sib piv ntawm Ib Leeg, Dual, thiab Quadruple Agonist Peptides hauv Kev Tswj Xyuas Metabolic." Molecular Metabolism, 62, 101562.
6. Lee, SH, et al. (2022). "Receptor Cross-Hais hauv Ntau-Agonist Peptide Therapies: Qhov cuam tshuam rau Kev Tswj Metabolic." Cell Metabolism, 34(3), 456-470.
